Remember
 
+
 
+
 Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
 
russurban Followed KIQ1 day ago
russurban Placed a 'Buy' Sentiment on VXRTMore than a week ago
russurban Placed a 'Buy' Sentiment on OTLKMore than a week ago
anonusers Placed a 'Sell' Sentiment on UNVC5 days ago
anonusers Placed a 'Buy' Sentiment on HOMEMore than a week ago
anonusers Placed a 'Sell' Sentiment on WBAMore than a week ago
stockarticles Placed a 'Buy' Sentiment on BBMore than a week ago
stockarticles Followed BBMore than a week ago
stockarticles Placed a 'Buy' Sentiment on SNAPMore than a week ago
 
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  VXRT  •  OTLK  •  PINS  •  BB  •  TWTR  •  CGC  •  ARCI  •  LULU  •  SNAP  •  IRBT

     
 

April 13, 2006

SpeculatingStocks.com Stock Pick: Amicus Therapeutics, Inc. (FOLD)

Stock Price: $3.93


Amicus Therapeutics is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration. The compan's lead program is in Phase 3 for the treatment of Fabry disease.

FOLD's President & CEO, John Crowley, is being portrayed by Brendan Fraser in the film "Extraordinary Measures." The film was just released yesterday (Friday, January 22nd) and is a major motion picture.

We believe "Extraordinary Measures" will bring greater attention to FOLD. Also, FOLD's risk to reward prospects at this time look attractive. FOLD has support around its current level and has spiked twice in the last month.

The biotech space has been heating up and we believe we could see FOLD become a great play moving forward.

FOLD has $89.27 million on the balance sheet in cash, cash equivalents and short-term investments. FOLD has 22.4 million shares in its float.

 
     
Untitled Document